Xtacy Therapeutics (TSE:XTCY) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Xtacy Therapeutics Corp. has announced that it will strengthen its financial position by issuing 3,580,500 common shares to settle CA$179,025 of debt owed to various creditors. The shares, priced at $0.05 each, will be subject to a four-month statutory hold period following issuance. This strategic move is aimed at reducing the company’s liabilities and improving its financial stability.
For further insights into TSE:XTCY stock, check out TipRanks’ Stock Analysis page.